Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. (Proceedings of the National Academy of Sciences of the United States of America, 2005)

(untitled) - Tate, S; Depondt, C; Sisodiya, S; Cavalleri, G; Schorge, S; Soranzo, N; Thom, M; Sen, A; Shorvon, S; Sander, J; Wood, N; Goldstein, D